Skip to main content

Teprotumumab-trbw Injection Shortage

Last Updated: April 12, 2021
Status: Resolved

Reason for the Shortage
    • Horizon Therapeutics had Tepezza on back order because the manufacturing facility is being used to make COVID-19 vaccine. Additional information can be found at or
Available Products
    • Tepezza intravenous lyophilized powder for injection, Horizon Therapeutics, 500 mg, single dose vial, 1 count, NDC 75987-0130-15

Estimated Resupply Dates

    • Horizon Therapeutics has Tepezza available.


Updated April 12, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 10, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.